Cervical Cancer Trials

From DolceraWiki
Revision as of 20:36, 6 October 2011 by Sonal.pingle (Talk | contribs)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to: navigation, search

To go back to the main page, click here

S.No. Drug Name Biological Name Developer Current Development Phase Additional Information Start Date Completion Date Source
11 E7-specific cancer vaccines - National Taiwan University Hospital - There are two main goals in this study. First, the investigators would like to establish and compare the differences of HPV type 16 E7-specific immunologic responses between the normal population, people with HPV infection, patients with cervical intraepithelial neoplastic (CIN) lesions, and patients with cervical cancer. Second, they would like to correlate the disease severity of cervical cancer with the immunologic responses to HPV type 16 E7 antigen 2003 2008 Source
12 - RG3484 Roche II - - - -
13 - Therapeutic
Vaccine
Transgene Preclinical - - - -




To go back to the main page, click here